Elevance Health
1,523 hedge funds and large institutions have $90.8B invested in Elevance Health in 2023 Q3 according to their latest regulatory filings, with 115 funds opening new positions, 575 increasing their positions, 572 reducing their positions, and 98 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 45 → 55 (+10)
17% more first-time investments, than exits
New positions opened: 115 | Existing positions closed: 98
13% more call options, than puts
Call options by funds: $619M | Put options by funds: $548M
1% more repeat investments, than reductions
Existing positions increased: 575 | Existing positions reduced: 572
0% more funds holding
Funds holding: 1,523 → 1,523 (0)
0.43% less ownership
Funds ownership: 88.58% → 88.15% (-0.43%)
2% less capital invested
Capital invested by funds: $93B → $90.8B (-$2.19B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$347M |
| 2 |
Eagle Capital Management (New York)
New York
|
+$287M |
| 3 |
BWA
Brave Warrior Advisors
New York
|
+$139M |
| 4 |
Two Sigma Advisers
New York
|
+$127M |
| 5 |
DCP
D1 Capital Partners
New York
|
+$122M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$710M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$628M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$333M |
| 4 |
State Street
Boston,
Massachusetts
|
-$242M |
| 5 |
Man Group
London,
United Kingdom
|
-$233M |
ELV Hedge Fund Activity: Q3 2023 in Review
1,523 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2023, worth a combined $90.8B — down 2.4% from $93B a quarter earlier.
Buyers outnumbered sellers: 115 funds opened new ELV positions and 98 closed out — a net gain of 17 holders — while 575 added to existing stakes and 572 trimmed.
The largest buyer was Millennium Management, adding an estimated $347M. The largest seller was Capital International Investors, cutting an estimated $710M.
- 1,523 institutional investors held Elevance Health (ELV) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $90.8B of Elevance Health stock for Q3 2023, down 2.4% quarter-over-quarter.
- 115 funds opened new Elevance Health positions in Q3 2023 and 98 closed out, a net change of +17 holders.
- The largest Elevance Health buyer in Q3 2023 was Millennium Management, an estimated $347M added.
- The largest Elevance Health seller in Q3 2023 was Capital International Investors, an estimated $710M sold.
Based on aggregated 13F filings for Q3 2023.